BlackRock Fund Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $407M | Buy |
13,038,135
+25,383
| +0.2% | +$793K | 0.08% | 264 |
|
|
2016
Q3 | $523M | Buy |
13,012,752
+430,044
| +3% | +$17.3M | 0.11% | 174 |
|
|
2016
Q2 | $418M | Buy |
12,582,708
+554,616
| +5% | +$18.4M | 0.09% | 209 |
|
|
2016
Q1 | $354M | Buy |
12,028,092
+12,231
| +0.1% | +$360K | 0.08% | 243 |
|
|
2015
Q4 | $316M | Buy |
12,015,861
+616,953
| +5% | +$16.2M | 0.07% | 276 |
|
|
2015
Q3 | $270M | Sell |
11,398,908
-206,058
| -2% | -$4.88M | 0.07% | 297 |
|
|
2015
Q2 | $275M | Buy |
11,604,966
+606,780
| +6% | +$14.4M | 0.07% | 321 |
|
|
2015
Q1 | $261M | Buy |
10,998,186
+445,452
| +4% | +$10.6M | 0.06% | 349 |
|
|
2014
Q4 | $224M | Buy |
10,552,734
+851,586
| +9% | +$18.1M | 0.06% | 391 |
|
|
2014
Q3 | $165M | Buy |
9,701,148
+362,970
| +4% | +$6.18M | 0.05% | 489 |
|
|
2014
Q2 | $134M | Sell |
9,338,178
-182,064
| -2% | -$2.6M | 0.04% | 659 |
|
|
2014
Q1 | $118M | Buy |
9,520,242
+224,562
| +2% | +$2.78M | 0.03% | 719 |
|
|
2013
Q4 | $102M | Buy |
9,295,680
+1,068,600
| +13% | +$11.7M | 0.03% | 828 |
|
|
2013
Q3 | $95.5M | Buy |
8,227,080
+402,096
| +5% | +$4.67M | 0.03% | 788 |
|
|
2013
Q2 | $87.6M | Buy |
+7,824,984
| New | +$87.6M | 0.03% | 751 |
|